TGA stands by decision to grant approval for AstraZeneca vaccine
The Therapeutic Goods Administration is standing firm on its decision to approve the AstraZeneca vaccine. The Head of the TGA, Dr John Skerritt, says the evidence remains in favour of the vaccine.